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Background: Cholangiocarcinoma is a serious public health in Thailand with increasing incidence and mortality
rates. The present study aimed to investigate cytotoxic activities of crude ethanol extracts of a total of 28 plants
and 5 recipes used in Thai folklore medicine against human cholangiocarcinoma (CL-6), human laryngeal (Hep-2),
and human hepatocarcinoma (HepG2) cell lines in vitro.
Methods: Cytotoxic activity of the plant extracts against the cancerous cell lines compared with normal cell line
(renal epithelial cell: HRE) were assessed using MTT assay. 5-fluorouracil was used as a positive control. The IC50
(concentration that inhibits cell growth by 50%) and the selectivity index (SI) were calculated.
Results: The extracts from seven plant species (Atractylodes lancea, Kaempferia galangal, Zingiber officinal, Piper
chaba, Mesua ferrea, Ligusticum sinense, Mimusops elengi) and one folklore recipe (Pra-Sa-Prao-Yhai) exhibited
promising activity against the cholangiocarcinoma CL-6 cell line with survival of less than 50% at the concentration
of 50 μg/ml. Among these, the extracts from the five plants and one recipe (Atractylodes lancea, Kaempferia
galangal, Zingiber officinal, Piper chaba, Mesua ferrea, and Pra-Sa-Prao-Yhai recipe) showed potent cytotoxic activity
with mean IC50 values of 24.09, 37.36, 34.26, 40.74, 48.23 and 44.12 μg/ml, respectively. All possessed high activity
against Hep-2 cell with mean IC50 ranging from 18.93 to 32.40 μg/ml. In contrast, activity against the hepatoma
cell HepG2 varied markedly; mean IC50 ranged from 9.67 to 115.47 μg/ml. The only promising extract was from
Zingiber officinal (IC50 = 9.67 μg/ml). The sensitivity of all the four cells to 5-FU also varied according to cell types,
particularly with CL-6 cell (IC50 = 757 micromolar). The extract from Atractylodes lancea appears to be both the
most potent and most selective against cholangiocarcinoma (IC50 = 24.09 μg/ml, SI = 8.6).
Conclusions: The ethanolic extracts from five plants and one folklore recipe showed potent cytotoxic activity
against CL-6 cell. Sensitivity to other cancerous cell lines varied according to cell types and the hepatocarcinoma
cell line. HepG2 appears to be the most resistant to the tested extracts.
Background
Cholangiocarcinoma, malignant epithelial cells that
arises within bile duct, is a serious public health in Thai-
land with increasing incidence and mortality. The cancer
occurs at a particularly high rate in Northeastern Thai-
land, with age-standardized incidence rate (ASRs) 33.4
per 100,000 in males and 12.3 per 100,000 in females
[1]. It accounts for approximately 15% of liver cancer
worldwide [2]. This cancer can be classified into three
major groups, i.e., intrahepatic, perihilar and distal
extrahepatic cholangiocarcinoma. Intrahepatic type is
the most common case of cholangiocarcinoma in Thai-
land and infestation of Opisthorchis viverrini has been
classified as a definite risk factor of the disease [3]. The
lack of early detection and limited therapeutic options
are major problems for controlling this type of cancer.
At present, surgical resection of detectable tumors leads
to an improvement in the 5-year survival rate. Adjunc-
tive therapy with chemotherapeutic agents has been
shown to improve local control, provide palliation, and
prolong survival [4]. Even those with operable tumor,
the recurrence rate is extremely high, with a 5-year
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treatment of cholangiocarcinoma is largely ineffective;
the standard chemotherapeutic agent, 5-fluorouracil (5-
FU) always produces low clinical response rate [6-8].
Advanced surgical techniques in conjunction with
alternative chemotherapeutic option with promising
activity are required to improve the survival of
patients. Cholangiocarcinoma is considered to be a
multidrug and radio-resistant tumor and still require
new approach of treatments [9].
Numerous cancer research for chemotherapeutic
potential of medicinal plants have been carried out in
an effort to discover new therapeutic agents that lack
the toxic effects associated with current therapeutic
agents. Traditional medicine is commonly used as an
alternative treatment for cancer by Thai people [10].
Several Thai traditional folklores have been shown to
possess anticancer activities in various human cancerous
cell lines with some promising candidates [11,12]. In the
present study, the ethanolic extracts of a total of 28
plants and 5 recipes used in Thai folklore medicine
were investigated for their cytotoxic activity in vitro
against three human cancerous cell lines, i.e., CL-6 (cho-
langiocarcinoma), Hep-2 (laryngeal carcinoma), HepG2
(hepatocarcinoma), and HRE (renal epithelial cells). To
our knowledge, this is the first study that focused on the




Commercial grade ethanol was purchased from Labscan
Co. Ltd. The cell culture medium and reagents were
purchased from different sources: Ham-12, RPMI 1640,
M-199 medium, from Gibco BRL Life Technologies
(Grand Island, NY, USA), renal epithelium cell growth
medium and SupplementPack from Promacell Co. Ltd.
(Germany). Fetal bovine serum (FBS), L-glutamine
dimethylsulfoxide (DMSO), the antibiotic solution,
streptomycin-penicillin and antibiotic-antimycotic, were
purchased from Gibco BRL Life Technologies. The
reference compound, 5-fluorouracil (5-FU) and MTT
[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide] were purchased from Sigma-Aldrich Inc. (St.
Louis, MO, USA).
Plant materials and preparation of crude extracts
Plant materials were collected from various parts of Thai-
land and some were purchased from the city markets.
Authentication of plant materials was carried out at the
herbarium of the Department of Forestry, Bangkok, Thai-
land, where the herbarium vouchers have been kept. A
duplicate set has been deposited in the herbarium of
Southern Center of Thai Medicinal Plants at the Faculty
of Pharmaceutical Science, Prince of Songkhla University,
Songkhla, Thailand.
The plant materials were rinsed thoroughly with tap
water to remove extraneous contaminants and cut into
small pieces, oven-dried at 50°C until stability of dry
weight was observed, and then ground into powder with
an electric-grinder. Extraction was carried out by macer-
ating the powdered plant materials (100 g) in stoppered
flasks containing 500 ml of 95% ethanol at room tem-
perature (25-30°C) for 7 days. The extracted solvent was
separated and filtered through Whatman no. 1 filter
paper. After filtration, the extracts were evaporated
under reduced pressure by rotary evaporation. The
crude extracts were weighed and stored at −20°C until
used.
Preparation of test materials and reference drug
The crude extract from each medicinal plant/recipe was
initially dissolved in 50% ethanol. Concentrated stock
solution of each extract was prepared by adding a
known weight of each crude extract to a known volume
of 50% ethanol, and then serially diluted (1:2) with com-
plete media to obtain the working solutions at eight
final concentrations. Positive control agent 5-FU was
prepared similarly as the crude extract by dissolving in
50% ethanol.
In vitro assay for cytotoxic activity
Human cell lines and cell culture
The cholangiocarcinoma cell line CL-6, human laryn-
geal carcinoma cell line Hep-2, human hepatocarcinoma
cell line HepG2 and normal human epithelial cell
(HRE) were used for cytotoxic screening of the medic-
inal plant extracts. CL-6 cell line was established and
kindly provided by Associate Professor Dr. Adisak
Wongkajornsilp, Department of Pharmacology, Faculty
of Medicine (Siriraj Hospital), Mahidol University, and
were cultured in Ham-12 medium supplemented with
10% heated fetal bovine serum and 100 IU/ml of anti-
biotic-antimycotic solution. Hep-2 cell line was obtained
from Department of Medical Technology, Faculty of
Allied Health Sciences, Thammasat University, estab-
l i s h e da n dc u l t u r e di nM - 1 99 medium supplemented
with 10% heated fetal bovine serum, 2.5 mM HEPES
(pH 7.4) and 100 IU/ml penicillin-streptomycin solu-
tion. HepG2 cell line was purchased from the Cell Line
Service Co. Ltd. (Germany) and was cultured in
DMEM: Ham’s F12 medium supplemented with 2 mM
L-glutamine, 10% fetal bovine serum and 100 IU/ml
pen-strep. Normal human renal epithelial cell line
( H R E )w a sp u r c h a s e df r o mP r o m o c e l lC o .L t d .
(Germany) and cultured in renal epithelial cell growth
medium 2 with SupplementPack. All cells were
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humidity.
Cytotoxic assay
The MTT colorimetric assay developed by Mosmann
[13] with modification was used to screen for cytotoxic
activity of all the plant extracts. Briefly, the cells were
seeded in 96-well plates at a density of 10
4 cells/well in
100 μl culture medium. Following 24-h incubation and
attachment, the cells were treated with different concen-
trations of plant extracts and 5-FU (positive control) for
24 h. Each extract was screened initially for its cytotoxi-
city against all cancerous and normal cell lines at the
concentration of 50 μg/ml. The potential candidates
which resulted in cell survival of less than 50% were
further assessed for their IC50 (concentration that inhi-
bits cell growth by 50%) values at the concentration
range of 250 and 1.95 μg/ml. The concentration range
used for 5-FU was 78.13 to 10,000 μM. Following wash-
ing and incubation with MTT solution (20 μlo f5m g /
ml) at 37°C for 3 h, cells were lyzed with DMSO. The
yellow MTT dye was reduced by succinic dehydrogenase
i nt h em i t o c h o n d r i ao fv i a b l ec e l l st op u r p l ef o r m a z a n
crystals. Absorbance (OD) was measured at 570 nm
using a microplate reader (Varioscan Flash, Thermo,
Finland). The percentage of cytotoxicity compared to
the untreated cells was determined with the equation:
Cell viability 
OD of treated cells




The results were generated from three independent
experiments; each experiment was performed in tripli-
cate. The IC50 values were calculated using CalcySyn™
(USA) software. The selectivity index (SI) was also cal-
culated from the IC50 ratio of normal epithelial and can-
cerous (CL-6, Hep-2, HepG2) cells. SI value indicates
selectivity of the sample to the cell lines tested. Samples
with SI value greater than 3 were considered to have
high selectivity.
Results and Discussion
Plants are promising source of anti-infective and antican-
cer chemotherapeutic agents. Saetung and colleague
selected twelve Thai medicinal plants as the ingredients
of a Southern Thai traditional folklore medicine for can-
cer treatment to test for their cytotoxicity activity against
human lung and prostate cancer cell lines. The ethanolic
extracts of the six plants (Bridelia ovata, Curcuma
zedoaria, Derris scandens, Dioscorea membranacea, Nar-
dostachys jatamansi and Rhinacanthus nasutus)s h o w e d
promising cytotoxic activity (IC50 <3 0μg/ml) [14]. In
the present study, the cytotoxic effect of a total of 28
ethanolic extracts of plants and 5 recipes from traditional
folklore medicine against the human cholangiocarcinoma
cell line CL-6 were investigated. In addition, their com-
parative activity against the other two human cancerous
cell lines, i.e., Hep-2 (laryngeal carcinoma) and HepG2
(hepatocarcinoma), and one normal cell HRE (human
renal epithelial cell) was also examined. These plants
have been used by Thai people to treat different illness.
The five recipes were used for restorativeness, treatment
of fever, cold and cancer (Table 1). The eighteen plants
tested were composition of Pra-Sa-Prao-Yhai recipe, and
some plants were composition of other recipes (Table 1).
The leave, stem, bark and rhizome parts of plants were
most often used for these traditional medicines (Table 1).
Results from the initial screening showed that the
extracts from seven plant species (Atractylodes lancea,
Kaempferia galangal, Zingiber officinal, Piper chaba,
Mesua ferrea, Ligusticum sinense, Mimusops elengi)a n d
one folklore recipe (Pra-Sa-Prao-Yhai) exhibited promis-
ing activity against the cholangiocarcinoma CL-6 cell line
with cell survival of less than 50% at the concentration of
50 μg/ml (Table 2). Among these, six (Atractylodes lan-
cea, Kaempferia galangal, Zingiber officinal, Piper chaba,
Mesua ferrea,a n dP r a - S a - P r a o - Y h ai recipe) showed
potent cytotoxic activity with IC50 values of less than 50
μg/ml. The potency of the extracts in descending order
w a sa sf o l l o w :Atractylodes lancea, Zingiber officinal,
Kaempferia galangal, Piper chaba, Pra-Sa-Prao-Yhai
recipe and Mesua ferrea (Table 3). The plants Atracty-
lodes lancea, Kaempferia galangal and Mesua ferrea are
also composition of Pra-Sa-Prao-Yhai recipe. In the US
National Cancer Institute Plant Screening Program, a
crude extract is generally considered to have in vitro
cytotoxic activity if the IC50 value in carcinoma cells, fol-
lowing incubation between 48 and 72 hours, is less than
20 μg/ml, while it is less than 4 μg/ml for pure com-
pounds [15]. Based on this criteria, only the extract from
Atractylodes lancea is considered highly active with IC50
of 24.04 ± 3.40 (mean ± SD) μg/ml. The extract from
Dioscorea membranacea showed only weak activity in
the screening test against cholangiocarcinoma cell. In our
previous study [11], water extract of this plant (DM1 and
DM2) exhibited promising cytotoxic activity against
human breast adenocarcinoma MCF-7 (IC50 = 7.7 μg/ml)
but only showed moderate activity against human large
cell lung carcinoma COR-L23 (IC50 = 37.6 μg/ml) and
human colon adenocarcinoma LS-174T (IC50 = 78.4 μg/
ml) cell lines [16].
Investigation of comparative cytotoxic activities of the
extracts of the six plants and the standard drug 5-FU
against CL-6, HepG-2 Hep-2 and HRE cell lines indicate
difference in responsiveness/sensitivity of different can-
cerous cells to these plant extracts (Table 3 and Figure 1).
The results were generally in agreement with that shown
in the screening test, confirming that Hep-2 was the
most sensitive, while HepG2 was the most resistant cell
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folklore. All extracts possessed high activity against Hep-
2 cell with mean IC50 values ranging from 18.93 to 32.40
μg/ml. In contrast, activity against the hepatoma cell
HepG2 varied markedly with mean IC50 values ranging
from 9.67 to 115.47 μg/ml. The only promising extract
was from Zingiber officinal (IC50 =9 . 6 7±3 . 9 1μg/ml).
The extract from Atractylodes lancea exhibited the most
potent activity against CL-6 but the activities against the
other two cancerous cells were only moderate. The
extract from Zingiber officinal was most promising
against HepG2 cell line, whereas that from Piper chaba
was most promising against Hep-2 cell. This may suggest
that HepG2 is the most resistant among the three cancer-
ous cell lines under investigation. Only two crude
extracts from Curcuma longa and Mammea siamensis
showed high activity against HepG2 cell. Crude extracts
from Curcuma longa exhibited high activity against both
H e p G 2a n dH e p - 2( %s u r v i v a lo f1 3 . 9a n d0 . 6 ,r e s p e c -
tively) but relatively low activity against CL-6 cell line (%
survival of 59.9). The ethanolic extract of Mammea sia-
mensis showed promising activity against only HepG2
cell (29.2%) with relatively low activity against CL-6 and
Hep-2 cell line with % survival of 51.4 and 59.5,






Compositae Artemisia annua L.
1 Rh SKP 051010101 Treatment of fever, hemorrhoids [31]
Compositae Atractylodes lancea (thung.) DC.
1 Rh SKP 051011201 Treatment of fever, colds, flu, sore throat [31]
Cruciferae Asclepias curassavica L.
1,4 Fl SKP 057121901 Used as analgesic [32]
Dioscoreaceae Dioscorea membranacea Rh SKP 062041305 Treatment of cancer [16]
Dracaenaceae Dracaena loureiri Gagnep.
1 St, Ba SKP 065041201 Treatment of cough, fever, inflammation [32]
Guttiferae Mammea siamensis Kosterm
1 Fl SKP 083131901 Restorative [31]
Guttiferae Mesua ferrea L
1 Fl SKP 083130601 Treatment of dyspepsia [31]
Myristicaceae Myristica fragrans Houtt.
1 Sd SKP 121130601 Treatment of uterus pain, diarrhea [33]
Myrtaceae Syzygium aromaticum (L.) Merr. & L.
M. Perry
1
Fl SKP 123190101 Treatment of toothache, bacterial infection [32]
Nelumbonaceae Nigella sativa Linn.
1,4 Sd SKP 160141901 Treatment of jaundice [32]
Piperaceae Piper chaba Linn
2,3 Fr SKP 146160301 Used as carminative, antidiarrheal [31]
Piperaceae Piper interruptum Opiz.
2,3 Lf SKP 146160901 Treatment of choke [31]
Piperaceae Piper sarmentosum Roxb.
2,3 Rt SKP 146161901 Treatment of fever, toothache, cough, asthma [31]
Plumbaginaceae Plumbago indica Linn.
2,3 Rt SKP 148160901 Treatment of rheumatism [32]
Smilacaceae Smilax corbularia Kunth Rh SKP 179190315 Treatment of cancer [16]
Sapotadeae Mimusops elengi L.
1 Fl SKP 171130501 Used as cordial, tonic. Treatment of syncope [32]
Umbelliferae Angelica dahurica Benth.
1 Rt SKP 199010401 Used as antipyretic, antiasthma, anticough [33]
Umbelliferae Angelica sinensis (Oliv.) Diels
1 Rh SKP 199010901 Treatment of bronchitis pleurisy [33]
Umbelliferae Anethum graveolens L.
1,4 Rt, Fr SKP 199010701 Used as carminative. Treatment of eye pain [32]
Umbelliferae Cuminum cyminum Linn.
1,4 Sd SKP 199030301 Treatment of dyspepsia, diarrhoea and jaundice [31]
Umbelliferae Foeniculum vulgare Mill. var. dulce
Alef.
1,4
Sd SKP 199062201 Used as analeptic [33]
Umbelliferae Ligusticum sinense Oliv. cv.
Chuanxiong
1
Rh SKP 199121901 Treatment of urinary bladder channel, headache, neurodermatitis [32]
Zingiberaceae Amomum testaceum Ridl.
1 Sd SKP 206011101 Used as carminative, antibacterial [33]
Zingiberaceae Curcuma longa Linn. Rh SKP 206012101 Treatment of cancer, high cholesterol, dyspepsia, gallstone [33]
Zingiberaceae Kaempferia galangal
1 Lf SKP 206110701 Antinociceptive, anti-inflammatory [33]
Zingiberaceae Zingiber officinale Roscoe.
2 Rh SKP 206261501 Treatment of hypercholesteremia and high level triglyceride [33]
Zingiberaceae Zingiber ligulatum Roxb
.3 Rh SKP 206261201 Used as anti-inflammatory [33]
- Dioscorea membranacea &Smilax
corbularia
- - Treatment of cancer [16]
- Ben-ja-Kul 1 Recipe - - Used as restorative [31]
- Ben-ja-Kul 2 Recipe - - Treatment of fever, cold [31]
- Pra-Sa-Prao-Yhai Recipe - - Used as restorative, anti-emetic, setting up proper digestive
system, analeptic [31]
- Tein-5 Recipe - - Used as restorative, carminative [31]
Plant parts: Fr: Fruits, Fl: Flower, Lf: leaves, Rt: Root, Rh: Rhizomes, Sd: Seed, St: Stem.
1Composition in Pra-Sa-Prao-Yhai Recipe,
2Composition in Ben-ja-Kul 1
Recipe,
3Composition in Ben-ja-Kul 2 Recipe,
4Composition in Tein-5 Recipe.
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Page 4 of 8Table 2 Percentage survival of cancer cell lines (CL-6, HepG2, Hep-2) treated with ethanolic extract from a total of 28
plants and 5 recipes used in Thai folklore medicine at the concentration of 50 μg/ml
Plant Cell line
CL-6 HepG2 Hep-2
Atractylodes lancea 32.10 ± 3.72 93.80 ± 8.09 -1.38 ± 0.67
Mesua ferrea 35.67 ± 8.66 64.62 ± 2.92 12.55 ± 6.03
Kaempferia galangal (leaf) 36.74 ± 11.72 75.03 ± 17.78 5.65 ± 0.08
Ligusticum sinense Oliv 43.85 ± 6.73 69.74 ± 4.46 36.81 ± 15.56
Zingiber officinal 44.26 ± 8.93 80.65 ± 11.92 8.11 ± 10.97
Artemisia annua 46.56 ± 6.03 95.76 ± 11.35 33.48 ± 7.85
Kaempferia galangal (flower) 47.49 ± 5.95 69.36 ± 16.12 9.74 ± 0.07
Mimusops elengi 48.84 ± 0.62 109.99 ± 2.95 54.44 ± 3.24
Pra-Sa-Prao-Yhai Recipe 49.43 ± 8.75 79.55 ± 23.90 25.55 ± 5.32
Piper chaba 50.62 ± 3.10 72.25 ± 1.15 12.42 ± 7.99
Mammea siamensis 51.35 ± 3.89 29.17 ± 12.28 59.52 ± 44.80
Angelica sinensis 51.77 ± 7.53 81.94 ± 12.48 33.77 ± 9.19
Syzygium aromaticum 55.40 ± 0.51 72.51 ± 15.32 34.30 ± 21.33
Nigella sativa 58.02 ± 2.25 118.49 ± 6.33 43.68 ± 0.49
Curcuma longa 59.86 ± 6.49 13.87 ± 12.88 0.57 ± 0.80
Ben-ja-Kul 1 Recipe 61.33 ± 2.84 87.19 ± 6.98 33.12 ± 9.68
Foeniculum vulgare 61.62 ± 8.86 83.26 ± 4.78 50.55 ± 11.04
Anethum graveolens 63.28 ± 12.92 97.47 ± 7.40 55.11 ± 4.37
Ben-ja-Kul 2 Recipe 63.78 ± 5.15 93.02 ± 9.15 46.27 ± 4.00
Piper pendulispicum 64.94 ± 5.78 62.66 ± 16.28 25.60 ± 14.67
Myristica fragrans 66.11 ± 2.11 89.14 ± 20.97 33.00 ± 13.32
Piper sarmentosum 69.20 ± 4.39 81.95 ± 10.79 34.09 ± 8.96
Amomum testaceum 72.30 ± 11.24 90.74 ± 12.47 71.24 ± 2.10
Cuminum cyminum 74.07 ± 6.38 87.25 ± 19.06 39.28 ± 7.50
Zingiber ligulatum 74.68 ± 2.17 106.55 ± 14.23 44.14 ± 2.28
Dioscorea membranacea 76.05 ± 2.57 90.86 ± 16.65 59.90 ± 29.93
Plumbago indica 77.79 ± 14.31 61.83 ± 20.45 40.50 ± 13.52
Tein-5 Recipe 79.73 ± 2.56 89.61 ± 16.60 63.21 ± 3.74
Dracaena loureiri 81.29 ± 10.42 96.18 ± 5.81 20.97 ± 28.05
Asclepias curassavica 81.63 ± 3.99 87.47 ± 13.67 47.45 ± 5.01
Smilax corbularia 81.77 ± 9.61 147.02 ± 18.39 68.96 ± 13.38
Dioscorea membranacea &Smilax corbularia 82.31 ± 0.39 141.96 ± 14.64 76.64 ± 13.42
Angelica dahurica 85.16 ± 5.55 80.18 ± 13.41 48.68 ± 2.68
Data are presented as mean ± SD from 3 independent experiments, triplicate for each).
Table 3 Cytotoxicity of 5-FU and ethanolic extracts from 5 medicinal plants and one recipe with promising activity
Plants Cell line
CL-6 HepG2 Hep-2 HRE
IC50 SI IC50 SI IC50 SI IC50
Atractylodes lancea 24.09 ± 3.40 8.6 76.68 ± 15.94 2.7 29.35 ± 8.66 7.1 207.59 ± 7.97
Kaempferia galangal (leaf) 37.36 ± 3.98 2.9 115.47 ± 26.23 0.9 18.99 ± 10.33 5.7 119.20 ± 14.91
Zingiber officinal 34.26 ± 7.65 3.5 9.67 ± 3.91 12.6 32.40 ± 6.70 3.8 121.50 ± 5.20
Piper chaba 40.74 ± 5.30 4.5 68.09 ± 22.58 2.7 18.93 ± 5.03 9.8 119.14 ± 9.94
Pra-Sa-Prao-Yhai recipe 44.12 ± 11.58 5.9 125.07 ± 3.08 2.11 20.99 ± 2.68 12.5 263.51 ± 29.06
Mesua ferrea 48.23 ± 5.84 2.5 86.47 ± 4.38 1.4 19.22 ± 5.31 6.3 121.77 ± 29.08
5-FU (μM) 757.00 ± 77.16 2.0 633.08 ± 284.25 2.4 141.49 ± 17.14 10.8 1542.20 ± 1529.11
Data are presented otherwise specified as mean ± SD of IC50 (μg/ml) from 3 independent experiments, triplicate for each.
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of the six tested extracts was determined by comparing
the cytotoxic activity (IC50) of each plant extract against
each cancerous cell with that of the normal human cell
HRE (Table 3). Results were expressed as selectivity
index (SI). SI of greater than3w a sc o n s i d e r e da sh i g h l y
selective. The extract from Atractylodes lancea appears
to be both the most potent and most selective against
cholangiocarcinoma (IC50 = 24.09 ± 3.40 μg/ml, SI 8.6),
whereas that from Zingiber officinal appears to be the
most potent and most selective against HepG2 (IC50 =
9.67 ± 3.91 μg/ml, SI = 12.6). For Hep-2 cell, Piper chaba
(IC50 = 18.63 ± 5.03 μg/ml, SI = 9.8) and Pra-Sa-Prao-
Yhai recipe (IC50 =2 0 . 9 9±2 . 6 8μg/ml, SI = 12.5) exhib-
ited the most promising and most selective cytotoxic
activity.
Difference in responsiveness/sensitivity of different
cancerous cells to different chemotherapeutics are com-
monly observed in various studies [11,12,17,18]. The
responsiveness of all the four cells to 5-FU varied accord-
ing to cell types, particularly with CL-6 cell (IC50 = 757 ±
72.16 μM). Although 5-FU is the standard chemothera-
peutic drug used in the treatment of human cholangio-
carcinoma, evidence of 5-FU resistance has been
reported both in vitro [9] and in vivo [7]. It has been
demonstrated in a previous study [19] that variations in
the sensitivity to chemotherapeutic drugs were observed
among the five intrahepatic cholangiocarcinoma cell lines
and sensitivity to chemotherapeutic drug. Cholangiocar-
cinoma is a fatal disease which is highly resistant to antic-
ancer drugs. It is noted that the IC50 values of 5-FU
observed in the present study and the previous study [19]
were much higher than those reported in other cancer-
ous cell lines, e.g., colon carcinoma (HCC-48, COLO20)
[20] and cervical squamous carcinoma (SiHa, HeLa) cell
lines [21]. This suggests low sensitivity of cholangiocarci-
noma to all chemotherapeutics including those obtained
from medicinal plant source, which is probably due in
part to enhanced resistance to apoptosis. Several genes
involved in the apoptosis, detoxification and efflux pro-
cesses have been reported to influence resistance to che-
motherapeutic agents, for examples multidrug resistance
protein (MDR1) and multidrug-resistance associated pro-
teins (MRPs) [22], glutathione-S-transferase (GST) [23],
dihydropyrimidine dehydrogenase (DPD) [24], and galec-
tin-3 [25]. Active compound from Atractylodes lancea
has been shown to exhibit strong inhibitory effects on 5-
lipoxygenase (5-LOX) and cyclooxygenase-1 (COX-1),
but exhibited only weak antioxidative activities [IC50 =
0.1 μM (5-LOX), 2 μM (COX-1), 9 μM (PMN/FMLP), 28
μM (PMN/OZ)] [26]. The alcoholic extracts of Kaemp-
feria galangal showed high cytotoxicity against SW 620
with IC50 less than 30 μg/ml and showed moderate cyto-
toxicity against cancer cells DU145 (human prostate can-
cer cell line), PA1 (human ovarian teratocarcinoma cell
line), and B16F10 (murine melanoma cells) and were not
Figure 1 Mean IC50 values of the ethanolic extracts from 5 plants and one recipe against 3 cancerous cell lines (CL-6, HepG2, Hep-2)
and one normal cell (HRE):A L=Atractylodes lancea,K G= Kaempferia galangal,Z O= Zingiber officinal,P C= Piper chaba, PSPYR = Pra-Sa-Prao-
Yhai recipe,M F= Mesua ferrea.
Mahavorasirikul et al. BMC Complementary and Alternative Medicine 2010, 10:55
http://www.biomedcentral.com/1472-6882/10/55
Page 6 of 8selective against cancer cells when compared to Vero
cells [27]. In the case of Zingiber officinal methanolic
extracts, cytotoxic activities against human A549 (adeno-
carcinomic alveolar basal epithelial cell line), SK-OV-3
(ovarian carcinoma cell line), SK-MEL-2 (skin Melanoma
cell line), and HCT15 (colon carcinoma cell line) have
been reported [28]. From the study of Sakpakdeejaroen et
al., piperine, the active compound of Piper chaba,
showed cytotoxic activity against MCF-7 (breast cancer
cell line) with IC50 equal to 35.72 μM [29]. The active
compounds of Mesua ferrea including phenylcoumarins,
xanthones and triterpenoids were reported to possess
cytotoxic and antibacterial activities [30].
Conclusions
Results obtained from this study indicate that 6 out of a
t o t a lo f2 8p l a n t sa n d5r e c i p e s( Atractylodes lancea,
Kaempferia galangal, Zingiber officinal, Piper chaba,
Mesua ferrea, and Pra-Sa-Prao-Yhai recipe) used in Thai
folklore medicine exhibited promising cytotoxic activity
against CL-6 human cholangiocarcinoma cell line. Sensi-
tivity to other cancerous cell lines varied according to
cell types and the hepatocarcinoma HepG2 appears to
be the most resistant cell line to the tested extracts. The
extract from Atractylodes lancea appears to be both the
most potent and most selective against cholangiocarci-
noma, whereas that from Zingiber officinal appears to
be the most potent and most selective against HepG2.
The extract from Piper chaba (IC50 =1 8 . 6 3μg/ml, SI =
9.8) and Pra-Sa-Prao-Yhai recipe (IC50 = 20.99 μg/ml, SI
= 12.5.) exhibited the most promising and most selective
cytotoxic activity against Hep-2 cell line. Further investi-
gation of all the six extracts for their cytotoxic activity
against cholangiocarcinoma in hamster model is under-
way to fully assess the anticancer activity in vivo.
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